These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14748665)

  • 1. Targeted cancer therapy with gonadotropin-releasing hormone chimeric proteins.
    Ben-Yehudah A; Lorberboum-Galski H
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):151-61. PubMed ID: 14748665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface antigens/receptors for targeted cancer treatment: the GnRH receptor/binding site for targeted adenocarcinoma therapy.
    Eaveri R; Ben-Yehudah A; Lorberboum-Galski H
    Curr Cancer Drug Targets; 2004 Dec; 4(8):673-87. PubMed ID: 15578922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing a GnRH-based chimeric protein for the detection of adenocarcinoma.
    Lichtenstein M; Ben-Yehudah A; Belostotsky R; Eaveri R; Sabag O; Grodzovski I; Lorberboum-Galski H
    Int J Oncol; 2005 Jul; 27(1):143-8. PubMed ID: 15942653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using apoptosis for targeted cancer therapy by a new gonadotropin releasing hormone-DNA fragmentation factor 40 chimeric protein.
    Ben-Yehudah A; Aqeilan R; Robashkevich D; Lorberboum-Galski H
    Clin Cancer Res; 2003 Mar; 9(3):1179-90. PubMed ID: 12631624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH-Bik/Bax/Bak chimeric proteins target and kill adenocarcinoma cells; the general use of pro-apoptotic proteins of the Bcl-2 family as novel killing components of targeting chimeric proteins.
    Azar Y; Lorberboum-Galski H
    Apoptosis; 2000 Dec; 5(6):531-42. PubMed ID: 11303912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer.
    Gnanapragasam VJ; Darby S; Khan MM; Lock WG; Robson CN; Leung HY
    J Pathol; 2005 Jun; 206(2):205-13. PubMed ID: 15818594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning, expression, and purification of a highly immunogenic recombinant gonadotropin-releasing hormone (GnRH) chimeric peptide.
    Xu J; Zhu Z; Duan P; Li W; Zhang Y; Wu J; Hu Z; Roque RS; Liu J
    Protein Expr Purif; 2006 Dec; 50(2):163-70. PubMed ID: 17064933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilizing chimeric proteins for exploring the cellular fate of endogenous proteins.
    Ben-Yehudah A; Aqeilan R; Belostotsky R; Azar Y; Lorberboum-Galski H
    Biochem Biophys Res Commun; 2002 Jan; 290(1):332-8. PubMed ID: 11779174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
    Harrison GS; Wierman ME; Nett TM; Glode LM
    Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases.
    Lorberboum-Galski H
    Expert Opin Drug Deliv; 2011 May; 8(5):605-21. PubMed ID: 21453191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
    Yan C; Wen-Chao L; Hong-Yan Q; Rui Z; Wei-Lin J; Hua H
    Acta Oncol; 2007; 46(6):773-81. PubMed ID: 17653900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
    Fister S; Günthert AR; Emons G; Gründker C
    Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition.
    Dälken B; Giesübel U; Knauer SK; Wels WS
    Cell Death Differ; 2006 Apr; 13(4):576-85. PubMed ID: 16179940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
    Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.
    Choi JH; Choi KC; Auersperg N; Leung PC
    Endocr Relat Cancer; 2006 Jun; 13(2):641-51. PubMed ID: 16728589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery.
    Asai T; Trinh R; Ng PP; Penichet ML; Wims LA; Morrison SL
    Biomol Eng; 2005 Feb; 21(6):145-55. PubMed ID: 15748688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands.
    Yao YC; Zhan XY; Zhang J; Zou XH; Wang ZH; Xiong YC; Chen J; Chen GQ
    Biomaterials; 2008 Dec; 29(36):4823-30. PubMed ID: 18824258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.